Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Clinical, biochemical, and molecular analysis of combined methylmalonic acidemia and hyperhomocysteinemia (cblC type) in China.
[homocystinuria without methylmalonic aciduria]
The
most
common
inborn
error
of
cobalamin
(
cbl
)
metabolism
in
China
is
the
cblC
type
characterized
by
combined
methylmalonic
acidemia
and
hyperhomocysteinemia
.
The
clinical
presentation
is
relatively
nonspecific
,
such
as
feeding
difficulty
,
recurrent
vomiting
,
hypotonia
,
lethargy
,
seizures
,
progressive
developmental
delay
,
and
mental
retardation
,
together
with
anemia
and
metabolic
acidosis
.
More
specific
biochemical
findings
include
high
levels
of
propionylcarnitine
(
C
3
)
,
free
carnitine
(
C
3
/
C
0
)
,
and
acetylcarnitine
(
C
3
/
C
2
)
measured
by
tandem
mass
spectrometry
(
MS
/
MS
)
,
elevation
of
methylmalonic
acid
(
MMA
)
measured
by
gas
chromatography-mass
spectrometry
(
GC
-
MS
)
,
and
increased
total
homocysteine
with
normal
or
decreased
methionine
.
We
report
on
50
Chinese
patients
with
combined
methylmalonic
acidemia
and
hyperhomocysteinemia
.
Forty
-
six
belonged
to
the
cblC
complementation
group
.
Mutation
analysis
of
the
MMACHC
gene
was
performed
to
characterize
the
mutational
spectrum
of
cblC
deficiency
,
and
17
different
mutations
were
found
.
Most
were
clustered
in
exons
3
and
4
,
accounting
for
91
.
3
%
of
all
mutant
alleles
.
Two
mutations
were
novel
,
namely
,
c
.
315
Â
C
>
G
(
p
.
Y
105
X
)
and
c
.
470
Â
G
>
C
(
p
.
W
157
S
)
.
In
terms
of
genotype-phenotype
correlation
,
the
c
.
609
Â
G
>
A
mutation
was
associated
with
early
-onset
disease
when
homozygous
.
Unlike
previous
reports
from
other
populations
,
c
.
609
Â
G
>
A
(
p
.
W
203
X
)
was
the
most
frequent
cblC
mutation
detected
in
our
study
of
Chinese
patients
,
affecting
51
of
92
MMACHC
alleles
(
55
.
4
%
)
.
The
high
prevalence
of
this
nonsense
mutation
could
have
potential
therapeutic
significance
for
Chinese
cblC
patients
.
Besides
traditional
approaches
consisting
of
hydroxocobalamin
injections
,
carnitine
,
betaine
,
and
protein
restriction
,
novel
drugs
that
target
premature
termination
codons
may
have
a
role
in
the
future
.
Diseases
Validation
Diseases presenting
"anemia"
symptom
22q11.2 deletion syndrome
alpha-thalassemia
canavan disease
child syndrome
coats disease
congenital toxoplasmosis
cowden syndrome
cutaneous mastocytosis
cystinuria
dedifferentiated liposarcoma
dracunculiasis
erythropoietic protoporphyria
esophageal adenocarcinoma
hirschsprung disease
holt-oram syndrome
homocystinuria without methylmalonic aciduria
kallmann syndrome
kindler syndrome
lamellar ichthyosis
liposarcoma
omenn syndrome
scrub typhus
sneddon syndrome
typhoid
waldenström macroglobulinemia
werner syndrome
wiskott-aldrich syndrome
This symptom has already been validated